Edgewise Therapeutics
EWTX
EWTX
176 hedge funds and large institutions have $2.7B invested in Edgewise Therapeutics in 2024 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 58 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
+36
Holders Change %
+25.71%
% of All Funds
2.55%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
51
Increased
58
Reduced
44
Closed
15
Calls
$60M
Puts
$13.3M
Net Calls
+$46.6M
Net Calls Change
+$45.7M
Top Buyers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
+$52.3M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$52.1M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$26.7M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$24.4M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$18.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$110M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$48.3M |
| 3 |
Goldman Sachs
New York
|
-$30.4M |
| 4 |
DM
Deerfield Management
New York
|
-$29.2M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$24M |
